Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
Oncolytics Biotech, Inc. (NASDAQ: ONCY) shares increased 4.71 percent to close at $2.89 a share Friday. The stock traded between $2.77 and $2.95 on volume of 842,043 shares traded. Analysts at Needham have recently initiated coverage on the company with a "buy" rating and a price target of $8.00. Shares of Oncolytics Biotech have fallen approximately 15.0 percent year-to-date.
Find out more about Oncolytics Biotech including full access to the free equity report at:
www.RDInvesting.com/ONCY
Rockwell Medical Inc. (NASDAQ: RMTI) shares surged 22.82 percent to close at $10.11 a share Friday. The stock traded between $8.75 and $10.20 on volume of 10.73 million shares traded. Analysts at Craig-Hallum have recently initiated coverage on the company with a "buy" rating and a price target of $16.00. Shares of Rockwell Medical have gained approximately 25.0 percent year-to-date.
Find out more about Rockwell Medical including full access to the free equity report at:
www.RDInvesting.com/RMTI
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares declined 1.39 percent to close at $38.34 a share Friday. The stock traded between $38.19 and $38.85 on volume of 2.83 million shares traded. Analysts at JPMorgan have recently downgraded the company’s rating to "neutral" from "overweight". Shares of Teva Pharmaceutical have gained approximately 2.7 percent year-to-date.
Find out more about Teva Pharmaceutical full access to the free equity report at:
www.RDInvesting.com/TEVA
Viropharma Inc. (NASDAQ: VPHM) shares soared 28.42 percent to close at $39.13 a share Friday. The stock traded between $30.21 and $39.56 on volume of 11.74 million shares traded. Analysts at Wells Fargo have recently downgraded the company’s rating to "market perform" from "outperform" based on valuation. Shares of Cobalt International Energy have gained approximately 6.0 percent year-to-date.
Find out more about Viropharma including full access to the free equity report at:
www.RDInvesting.com/VPHM
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com